Veenat 400mg Imatinib – CML & GIST Tyrosine Kinase Inhibitor

Veenat 400 (Imatinib) (generic equivalent to Gleevec / Glivec) is a prescription targeted oncology medication for the treatment of chronic myeloid leukaemia (CML), acute lymphocytic leukaemia (ALL), and gastrointestinal stromal tumours (GIST). As a targeted therapy, it works at a molecular level to slow cancer cell proliferation while sparing healthy tissue.
Composition: Imatinib (400mg)
Manufacturer: Natco Pharma Ltd
Prescription-only oncology medication. Use only under the direct supervision of a licensed oncologist. Regular blood tests and monitoring are mandatory throughout treatment.